类酸及其类型:对脏疾病有前途的治疗方法
Dan Pan1,2, Yilun Qu2, Chunru Shi1,2
1The College of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Chinese medicine
|May 30, 2024
概括
类酸 (OA) 是一种天然化合物,通过减少炎症和氧化应激,显示出治疗脏疾病的前景. 对OA及其衍生物的进一步研究可能会导致更安全,更有效的病治疗方法.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 自然产品化学 自然产品化学
背景情况:
- 脏疾病是全球主要的健康问题,死亡率高.
- 目前用于治疗脏疾病的治疗方法具有显著的副作用,需要更安全的替代方案.
- 烯酸 (OA) 是一种天然的五环三烯酸,具有潜在的保护性.
研究的目的:
- 综合审查植物来源,药理动力学,衍生品和醇酸 (OA) 的安全性.
- 概述OA及其类似物在病中的治疗作用,包括抗炎,免疫调节,抗氧化,自增强和抗纤维活性.
- 分析OA在脏疾病中的作用背后的分子机制,以指导新药开发.
主要方法:
- 对植物来源,药理动力学和烯酸 (OA) 的安全性概况的文献综述.
- 在各种病模型中对OA及其类型的疗效进行临床前和临床研究的系统摘要.
- 分子通路的分析,包括抗炎,抗氧化,免疫调节,自和抗纤维机制.
主要成果:
- 醇酸 (OA) 具有对脏健康有益的多种药理活性.
- 在脏疾病的临床前模型中,OA表现出抗炎,免疫调节,抗氧化,自增强和抗纤维作用.
- 已经合成了OA的各种衍生物,其中一些显示出增强的治疗潜力.
结论:
- 醇酸 (OA) 和其衍生物代表了一类有前途的天然化合物,用于开发治疗脏疾病的新疗法.
- 了解OA脏保护作用的分子机制对于优化其临床应用至关重要.
- 需要进一步的研究,以将OA的治疗潜力转化为患有脏疾病的患者的安全和有效治疗方法.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:25Antihypertensive Drugs: Direct Renin Inhibitors
585
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
585
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
512
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
512
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
617
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
617
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
711
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
711